Posts

Showing posts with the label Pomahope 1mg capsules

Pomahope 1mg capsules | Pomalidomide |Millionpharma

Image
POMAHOPE 1MG POMAHOPE 1MG DESCRIPTION Pomalidomide is sold under the brand name Pomahope 1mg and it belongs to anti-neoplastic drugs Pomahope 1mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 1mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 1mg capsules is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 1mg capsules is used by combining with dexamethasone. Pomahope 1mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 1mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological ac...

Pomahope 1mg capsules | Pomalidomide |Millionpharma

Image
POMAHOPE 1MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 1mg and it belongs to anti-neoplastic drugs Pomahope 1mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 1mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 1mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 1mg is used by combining with dexamethasone. P omahope 1mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 1mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope 1mg capsules has three primary pharmacological ac...